Similar articles for PMID: 21233185

Year	Number of Results
1997	1
2000	2
2002	4
2003	5
2004	9
2005	3
2006	3
2007	9
2008	2
2009	3
2010	7
2011	8
2012	4
2013	8
2014	7
2015	8
2016	6
2017	3
2018	2
2019	8
2020	4
2021	1
2023	0

1

Variations in PET/CT methodology for oncologic imaging at U.S. academic medical centers: an imaging response assessment team survey.

Graham MM, Badawi RD, Wahl RL. Graham MM, et al. J Nucl Med. 2011 Feb;52(2):311-7. doi: 10.2967/jnumed.109.074104. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233185 Free PMC article.

2

Variations in clinical PET/CT operations: results of an international survey of active PET/CT users.

Beyer T, Czernin J, Freudenberg LS. Beyer T, et al. J Nucl Med. 2011 Feb;52(2):303-10. doi: 10.2967/jnumed.110.079624. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233186 Free article.

3

Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.

Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J. Halpern BS, et al. J Nucl Med. 2004 May;45(5):797-801. J Nucl Med. 2004. PMID: 15136629 Free article.

4

Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters.

Galavis PE, Hollensen C, Jallow N, Paliwal B, Jeraj R. Galavis PE, et al. Acta Oncol. 2010 Oct;49(7):1012-6. doi: 10.3109/0284186X.2010.498437. Acta Oncol. 2010. PMID: 20831489 Free PMC article.

5

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

6

A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.

Lartizien C, Kinahan PE, Comtat C. Lartizien C, et al. J Nucl Med. 2004 Apr;45(4):714-23. J Nucl Med. 2004. PMID: 15073270 Free article.

7

Image Quality and Activity Optimization in Oncologic ¹⁸F-FDG PET Using the Digital Biograph Vision PET/CT System.

van Sluis J, Boellaard R, Dierckx RAJO, Stormezand GN, Glaudemans AWJM, Noordzij W. van Sluis J, et al. J Nucl Med. 2020 May;61(5):764-771. doi: 10.2967/jnumed.119.234351. Epub 2019 Oct 18. J Nucl Med. 2020. PMID: 31628214 Free article.

8

Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.

Everaert H, Vanhove C, Lahoutte T, Muylle K, Caveliers V, Bossuyt A, Franken PR. Everaert H, et al. Eur J Nucl Med Mol Imaging. 2003 Dec;30(12):1615-9. doi: 10.1007/s00259-003-1317-8. Epub 2003 Sep 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 14504831

9

Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG.

Israel O, Mor M, Gaitini D, Keidar Z, Guralnik L, Engel A, Frenkel A, Bar-Shalom R, Kuten A. Israel O, et al. J Nucl Med. 2002 Sep;43(9):1129-36. J Nucl Med. 2002. PMID: 12215549 Free article.

10

Oncologic PET/CT: current status and controversies.

Siegel BA, Dehdashti F. Siegel BA, et al. Eur Radiol. 2005 Nov;15 Suppl 4:D127-32. doi: 10.1007/s10406-005-0116-7. Eur Radiol. 2005. PMID: 16479662 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed